Neutral impactCompany
Stocks To Watch Today: Sun Pharma, Schaeffler India, Infosys, Titan And Orchid Pharma
NDTV Profit 2 hrs ago·21 Oct 2026, 12:30 am
Schaeffler India has announced its unaudited financial results for the quarter ended March 31, 2025. The company has reported a significant rise in its net profit, driven by strong sales growth across its automotive and industrial segments. This performance reflects the robust demand for its products and efficient cost management.
For investors, this news is a positive signal, indicating the company's continued operational strength and ability to generate value. The growth in profit margins suggests that the company is well-positioned to navigate the current economic environment. It reinforces confidence in the management's execution capabilities.
Investors should now focus on the company's future guidance regarding capacity utilization and order inflows. Monitoring the management's commentary on global supply chain dynamics will be crucial to understanding the sustainability of this growth trajectory.
Affected stocks
Neutral4 stocks
Schaeffler India
SCHAEFFLER Neutral
₹3,623.40
ORCHPHARMA
ORCHPHARMA Neutral
—
SUNPHARMA
SUNPHARMA Neutral
—
INFY
INFY Neutral
—
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Schaeffler India (SCHAEFFLER).
- Category: Company.
- Also mentions ORCHPHARMA, SUNPHARMA, INFY.
Why it matters
A routine update for Schaeffler India. Use the price and stock snapshot to gauge how the market is responding.
